Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (671-680 of 1,482) with videos related to

Pageof 149
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|September 11, 2014
Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromesDebora Mancini-DiNardo, Thaddeus Judkins, Nick Woolstenhulme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid LeukemiaDaniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
American Journal of Hematology|February 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemiaJayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Microbiology Spectrum|November 17, 2025
Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in AlaskaBryce Inman, Jeremy Butler, Soren George-Nichol, et al.
Leukemia Research|April 2, 2024
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AMLAlberto Risueño, Wendy L See, Iryna Bluemmert, et al.
Leukemia & Lymphoma|December 6, 2023
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patientsWei-Ying Jen, Koji Sasaki, Caitlin R Rausch, et al.
Plos One|August 27, 2013
Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromesSophie Dimicoli, Yue Wei, Carlos Bueso-Ramos, et al.
Cancer Medicine|July 20, 2024
Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignanciesCourtney D DiNardo, Rebecca Olin, Eunice S Wang, et al.
Genetics and Molecular Research : GMR|November 26, 2016
Microsatellite loci and genetic structure of artificial populations of Cotesia flavipes (Hymenoptera, Braconidae)L O S Anjos, R F Peixoto, D M S Chanquinie, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 21, 2017
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive LeukemiaRita Assi, Hagop Kantarjian, Nicholas J Short, et al.
Pageof 149

Showing results (671-680 of 1,482) with videos related to

Sort By:
Pageof 149
Journal of Experimental & Clinical Cancer Research : CR|September 11, 2014
Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromesDebora Mancini-DiNardo, Thaddeus Judkins, Nick Woolstenhulme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid LeukemiaDaniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
American Journal of Hematology|February 12, 2022
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemiaJayastu Senapati, Mahran Shoukier, Guillermo Garcia-Manero, et al.
Microbiology Spectrum|November 17, 2025
Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in AlaskaBryce Inman, Jeremy Butler, Soren George-Nichol, et al.
Leukemia Research|April 2, 2024
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AMLAlberto Risueño, Wendy L See, Iryna Bluemmert, et al.
Leukemia & Lymphoma|December 6, 2023
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patientsWei-Ying Jen, Koji Sasaki, Caitlin R Rausch, et al.
Plos One|August 27, 2013
Overexpression of the toll-like receptor (TLR) signaling adaptor MYD88, but lack of genetic mutation, in myelodysplastic syndromesSophie Dimicoli, Yue Wei, Carlos Bueso-Ramos, et al.
Cancer Medicine|July 20, 2024
Phase 1 dose escalation study of the MDM2 inhibitor milademetan as monotherapy and in combination with azacitidine in patients with myeloid malignanciesCourtney D DiNardo, Rebecca Olin, Eunice S Wang, et al.
Genetics and Molecular Research : GMR|November 26, 2016
Microsatellite loci and genetic structure of artificial populations of Cotesia flavipes (Hymenoptera, Braconidae)L O S Anjos, R F Peixoto, D M S Chanquinie, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 21, 2017
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive LeukemiaRita Assi, Hagop Kantarjian, Nicholas J Short, et al.
Pageof 149